An expert panel recommended FDA to approve the Pfizer-BioNTech COVID-19 vaccine for children ages five to 11
On Tuesday, an expert committee advising the Food and Drug Administration recommended that regulators authorize Pfizer-BioNTech’s COVID-19 vaccine for 5-…